Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer

PURPOSE: The aim of this study was to evaluate the therapeutic efficacy and safety of trastuzumab emtansine (T-DM1) for the treatment of patients with human epidermal growth factor receptor 2-positive breast cancer. METHODS: We performed a systemic review and meta-analysis of the relevant published...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Onco Targets Ther
Prif Awduron: Ma, Bo, Ma, Qianqian, Wang, Hongqiang, Zhang, Guolei, Zhang, Huiying, Wang, Xiaohong
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2016
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4778787/
https://ncbi.nlm.nih.gov/pubmed/27013890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S100499
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg